And despite CF being often described as a Th17-dominated disorder (58), the disease-dependent reduction of CCR6+ pb ILCs was restricted to the ILC2 subset rather than ILC3s or ILC1s (Figures S2B,C). This evidence concerns the gene CCR6 and cystic fibrosis.